Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised Medicine.
Vellekoop H, Huygens S, Versteegh M, Szilberhorn L, Zelei T, Nagy B, Koleva-Kolarova R, Tsiachristas A, Wordsworth S, Rutten-van Mölken M; HEcoPerMed Consortium. Vellekoop H, et al. Among authors: versteegh m. Pharmacoeconomics. 2021 Jul;39(7):771-788. doi: 10.1007/s40273-021-01010-z. Epub 2021 Apr 16. Pharmacoeconomics. 2021. PMID: 33860928 Free PMC article.
The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis.
Vellekoop H, Versteegh M, Huygens S, Corro Ramos I, Szilberhorn L, Zelei T, Nagy B, Tsiachristas A, Koleva-Kolarova R, Wordsworth S, Rutten-van Mölken M; HEcoPerMed consortium. Vellekoop H, et al. Among authors: versteegh m. Value Health. 2022 Aug;25(8):1428-1438. doi: 10.1016/j.jval.2022.01.006. Epub 2022 Mar 2. Value Health. 2022. PMID: 35248467 Free article. Review.
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.
Koleva-Kolarova R, Buchanan J, Vellekoop H, Huygens S, Versteegh M, Mölken MR, Szilberhorn L, Zelei T, Nagy B, Wordsworth S, Tsiachristas A; HEcoPerMed Consortium. Koleva-Kolarova R, et al. Among authors: versteegh m. Appl Health Econ Health Policy. 2022 Jul;20(4):501-524. doi: 10.1007/s40258-021-00714-9. Epub 2022 Apr 4. Appl Health Econ Health Policy. 2022. PMID: 35368231 Free PMC article.
Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib.
Huygens S, Vellekoop H, Versteegh M, Santi I, Szilberhorn L, Zelei T, Nagy B, Tsiachristas A, Koleva-Kolarova R, Wordsworth S, Rutten-van Mölken M; HEcoPerMed Consortium. Huygens S, et al. Among authors: versteegh m. Value Health. 2023 Feb;26(2):193-203. doi: 10.1016/j.jval.2022.08.006. Epub 2022 Oct 11. Value Health. 2023. PMID: 36229359 Free article.
238 results